3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gastrointestinal
1
Conditions
Neuritis
1
Lung Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Interventions
pembrolizumab
13
Gemcitabine
9
Cisplatin
7
Cetuximab
7
Psychiatric Rehabilitation
6
Paclitaxel
6
Magnetic Resonance Spectroscopy
6
Fluorouracil
6
Early Intervention, Educational
6
Carboplatin
6
cediranib
5
Leucovorin
5
sargramostim
4
Standard of Care
4
Pemetrexed
4
Oxaliplatin
4
Methods
4
Erlotinib Hydrochloride
4
Docetaxel
4
Cyclophosphamide
4
selpercatinib
3
aldesleukin
3
adagrasib
3
Trastuzumab
3
Therapeutics
3
Nivolumab
3
Irinotecan
3
Fluorodeoxyglucose F18
3
Bortezomib
3
Bevacizumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
Bestrophins
×
Thoracic
×
Clear all
NCT07427537
2026-02-23
miR-CIPN#1
University Hospital, Clermont-Ferrand
Phase NA
Recruiting
90 enrolled